Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
496.83
+16.70 (3.48%)
At close: Feb 27, 2026, 4:00 PM EST
496.10
-0.73 (-0.15%)
After-hours: Feb 27, 2026, 7:58 PM EST
Vertex Pharmaceuticals Analyst Ratings
Total Analysts
27
Consensus Rating
Buy
Price Target
$526.79
Upside
+6.03%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $411 → $441 | Hold | Maintains | $411 → $441 | -11.24% | Feb 17, 2026 |
| Barclays | Barclays | Buy Maintains $606 → $607 | Buy | Maintains | $606 → $607 | +22.17% | Feb 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $518 → $591 | Strong Buy | Maintains | $518 → $591 | +18.95% | Feb 17, 2026 |
| Scotiabank | Scotiabank | Hold Maintains $495 → $558 | Hold | Maintains | $495 → $558 | +12.31% | Feb 13, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $546 → $541 | Buy | Maintains | $546 → $541 | +8.89% | Feb 13, 2026 |
| Stifel | Stifel | Hold Maintains $445 → $466 | Hold | Maintains | $445 → $466 | -6.21% | Feb 13, 2026 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $540 | Hold → Buy | Upgrades | $540 | +8.69% | Feb 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $478 → $518 | Strong Buy | Maintains | $478 → $518 | +4.26% | Feb 13, 2026 |
| Barclays | Barclays | Hold → Buy Upgrades $414 → $606 | Hold → Buy | Upgrades | $414 → $606 | +21.97% | Jan 28, 2026 |
| UBS | UBS | Strong Buy Maintains $535 → $545 | Strong Buy | Maintains | $535 → $545 | +9.70% | Jan 26, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $475 → $530 | Buy | Maintains | $475 → $530 | +6.68% | Jan 23, 2026 |
| RBC Capital | RBC Capital | Hold → Buy Upgrades $455 → $546 | Hold → Buy | Upgrades | $455 → $546 | +9.90% | Jan 22, 2026 |
| Bernstein | Bernstein | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Jan 12, 2026 |
| UBS | UBS | Strong Buy Initiates $546 → $535 | Strong Buy | Initiates | $546 → $535 | +7.68% | Jan 7, 2026 |
| Wolfe Research | Wolfe Research | Hold → Buy Upgrades $548 | Hold → Buy | Upgrades | $548 | +10.30% | Jan 6, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $456 → $525 | Buy | Maintains | $456 → $525 | +5.67% | Dec 29, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.